Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontarget--a call for more circumspection-Reference-Cited by-同舟云学术

Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontarget--a call for more circumspection

Published:2008-09-10 Issue:3 Volume:102 Page:155-167
ISSN:1460-2725
Container-title:QJM
language:en
Short-container-title:QJM

Author:

Onuigbo M.A.C.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/qjmed/article-pdf/102/3/155/4560207/hcn142.pdf

Reference75 articles.

1. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

2. Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

3. Blood pressure effects of the angiotensin II receptor blocker, losartan

4. Losartan in Heart Failure

5. Angiotensin II receptor inhibition. A new therapeutic principle

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Care;Geriatric Medicine;2024

2. A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers;Reviews in Cardiovascular Medicine;2023-04-13

3. Surgical Care;Geriatric Medicine;2023

4. A Four-Year Report on Renal Outcomes Following the Elective Withdrawal of Long-Term Renin-Angiotensin-Aldosterone Blockade in a Cohort of Patients With Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury;Cureus;2022-10-28

5. Four-Year Report on Renal Outcomes Following Elective Withdrawal of Long-Term RAAS Blockade in a Cohort of Patients with Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury;2022-08-05